Atlas Trials

BE Study of the Combinations of Gemigliptin 50mg and Metformin HCl Extended Release 500mg in Comparison to Each Component Administered Alone

Clinical trial NCT01595880 · COMPLETED

Trial details

NCT number
NCT01595880
Sponsor
LG Life Sciences
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy
Start date
2014-12-01
Primary completion
2015-01-01
Enrollment
29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.